期刊文献+

脑梗死患者二级预防中阿司匹林抵抗现象及干预措施 被引量:3

下载PDF
导出
摘要 目的:观察脑梗死二级预防中阿司匹林抵抗现象,并分析其干预措施。方法325例脑梗死患者于入院当天起每晚顿服拜阿司匹林200 mg,7~10 d后检测血小板聚集率(MAR),筛选出阿司匹林抵抗、半反应者98例(随机分为3组,A组改用氯吡格雷,B组改用阿司匹林+氯吡格雷,C组继续服用拜阿司匹林)和敏感者227例(续服拜阿司匹林)。10 d后复查MAR。结果与同组调整前比较,A组调整后花生四烯酸( AA)诱导MAR升高,二磷酸腺苷(ADP)诱导MAR降低(P均<0.05);与同组调整前比较,B组调整后AA诱导、ADP诱导MAR均降低(P均<0.05)。结论脑梗死二级预防中阿司匹林抵抗现象发生率高,阿司匹林联合氯吡格雷双重抗血小板治疗可有效改善阿司匹林抵抗。
出处 《山东医药》 CAS 2014年第47期52-53,共2页 Shandong Medical Journal
  • 相关文献

参考文献10

二级参考文献29

  • 1韩雅玲.冠心病抗血小板治疗[J].武警医学,2006,17(3):163-165. 被引量:8
  • 2张微微.比较氯吡格雷与阿司匹林加埃索美拉唑对复发性溃疡出血的预防作用的点评[J].实用心脑肺血管病杂志,2006,14(1):22-22. 被引量:3
  • 3Berry C, Tardif J C, Bourassa M G. Coronary heart disease in patients with diabetes. Part I Recent advances in prevention and noninvasive management [J]. J Am Coll Cardiol, 2007,49 (6) :631-642.
  • 4Hammoud T, Tanguay J F, Bourassa M G. Management of coronary artery disease: therapeutic options in patients with diabetes [ J ]. J Am Coll Cardiol, 2000,36 (2) : 355-365.
  • 5Ogawa H, NakayamaM, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial [J]. JAMA, 2008,300(18) : 2134-2141.
  • 6Sabatine M S, Cannon C P, Gibson C M, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation [J]. N Engl J Med, 2005, 352(12) : 1179-1789.
  • 7Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol, 1971,231:232~235.
  • 8Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trial of antiplatelet therapy-I: prevention of death,myocardial infarction,and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ, 1994,308:81~246.
  • 9Gum P A, Kottke-Marchant K, Poggio E D, et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol, 2001,88:230~235.
  • 10Pappas J M, Westengard J C, Bull B S. Population variability in the effect of aspirin on platelet function:implications for clinical trials and therapy. Arch Pathol Lab Med, 1994,118:801~804.

共引文献120

同被引文献29

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15750
  • 2朱爱军.阿司匹林与氯吡格雷双重抗血小板治疗急性脑梗死疗效观察[J].医药前沿,2013,3(9):154-155.
  • 3秦世政.阿司匹林抵抗现象及干预在脑梗死二级预防中的随访研究[J/CD].世界最新医学信息文摘:电子版,2014,14(33):207-208.
  • 4Blann AD, Kuzniatsova N,Velu S, et al. Renal function and aspirin resistance in patients with coronary artery .dis- ease [J]. Thromb Res, 2012,130(3) : e103-e106.
  • 5Lin L,Jian C,Li F,et al. Prevalence and risk factors for aspirin resistance in elderly patients with type 2 diabetes [J]. International Journal of Gerontology, 2011,5 (2) : 112 -116.
  • 6Whitea RE, Gerrityb R, Barmana SA, et al. Estrogen and oxidative stress:A novel mechanism that may increase the risk for cardiovascular disease in women [J]. Steroids, 2010,75 ( 11 ) : 788-793.
  • 7Simpson SH, Gamble JM, Mereu L, et al. Effect of aspirin dose on mortality and cardiovascular events in people with diabetes:a meta-analysis [J]. J Gen Intern Med,2011, 26(11) : 1336-1344.
  • 8Ford ES,Zhao G,Li C. Pre-diabetes and the risk for cardio-vascular disease:a systematic review of the evi- dence [J]. J Am Coil Cardiol,2010,55(13) : 1310-1317.
  • 9Lev EI,Patel RT,Maresh KJ,et al. Aspirin and clopido- grel drug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistance [J]. J Am Coil Cardiol,2006,47(1):27-33.
  • 10唐海沁,杨维维,胡世莲,沈干,吴泰相,徐维平,殷实.氯吡格雷与阿司匹林抗血小板治疗ST段抬高型急性心肌梗死患者的系统评价[J].中华老年医学杂志,2009,28(2):143-148. 被引量:32

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部